HR 7839
116th Congress
House
Health
Congressional oversight
Drug therapy
Government studies and investigations
Health programs administration and funding
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
Continuing Access to In-Home IVIG Act
Introduced: July 29, 2020
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 29, 2020
Referred to the Subcommittee on Health.
Jul 29, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 29, 2020
Introduced in House
Plain-English summary
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3